Triptolide and its clinically relevant pro-drug Minnelide target high-risk MYC amplified medulloblastoma
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP491321
下载链接
链接失效反馈官方服务：
资源简介：
Pre-clinical validation of the triptolide's pro-drug Minnelide for the treatment of medulloblastomas classified as group 3 and harboring MYC amplifications.
创建时间：
2025-03-27
